SFN treatment of rats with middle cerebral artery occlusion inhibited the activation of inflammatory vesicles and the expressions of caspase-1, IL-1β and IL-18, reduced the volume of cerebral infarction, improved the score of neurological function, and reduced neutrophil infiltration (Yu et al., 2017). The gene discussed is IL18; the disease is brain infarction.